GlassScriptPhysician profile
Loraine B Nolla
NPI 1386600989
$1,207.13
in general payments reported to CMS, 2019-2025
18 companies · $14.47 in 2025
The $14.47 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.25 · 2020: $72.42 · 2021: $545 · 2022: $372 · 2023: $122 · 2024: $51.22 · 2025: $14.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $187.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $231.23 | 2020-2023 | |
| Abbvie INC. | $183.44 | 2020-2021 | |
| Daiichi Sankyo INC. | $132.78 | 2021 | |
| Medtronic, INC. | $95.47 | 2022 | |
| Alexion Pharmaceuticals, INC. | $83.57 | 2021 | |
| Minerva Surgical, INC | $80.18 | 2022-2025 | |
| Novo Nordisk INC | $66.84 | 2021-2023 | Wegovy |
| Organon LLC | $63.02 | 2022-2024 | |
| Gynesonics, INC. | $61.86 | 2022 | |
| Hologic Sales and Service, LLC | $54.57 | 2021-2023 | Aptima, Thinprep 2000 Processor, Third Wave |
| Bayer Healthcare Pharmaceuticals INC. | $48.97 | 2019-2023 | |
| Scynexis, INC. | $19.95 | 2022 | |
| Therapeuticsmd, INC. | $17.53 | 2021 | |
| Astellas Pharma US INC | $14.72 | 2024 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.48 | 2024 | Xifaxan |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.98 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $13.16 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loraine Nolla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.